J.Jpn. Surg. Soc.
ISSN 1880-1129

[Abstract] [Full Text HTML] [Full Text PDF] （in Japanese / 332KB） [Members Only]

J.Jpn. Surg. Soc.. 108(3): 116-119, 2007

Feature topic

VALUE OF POSTOPERATIVE SURVEILLANCE OF TUMOR RECURRENCE AFTER CURATIVE ESOPHAGEACTOMY

1) Department of Gastroenterological Surgery, Toranomon Hospital
2) Department of Thoracic Surgery, Respiratory Center, Toranomon Hospital
3) Department of Esophagogastroenterological Surgery, Juntendo University, Tokyo, Japan

Harushi Udagawa1), Kenji Tsutsumi1), Yoshihiro Kinoshita1), Masaki Ueno1), Shinji Mine1), Kazuhisa Ehara1), Tadasu Kohno2), Masahiko Tsurumaru3)

A study of 256 patients whose dates and patterns of first mode of recurrence after curative esophagectomy from 1984 to 2004 revealed the recent improvement in survival after the detection of tumor recurrence. This tendency was evident in lymphatic recurrence, particularly in the cervical area. Lung metastasis was another mode of recurrence that has shown recent improvement. In this series, 20 patients with lymph node metastases underwent reoperation for local or regional tumor control. The addition of systemic chemotherapy or chemoradiotherapy was our general rule. The 5-year survival rate after the detection of tumor recurrence in these 20 patients was 47.4%. Six with lung metastases in the group of patients whose esophagectomies were performed in the last 7 years underwent video-assisted pulmonary tumor resection. Five patients in this group are alive without signs of further recurrence for 92 to 1,437 days. The early detection of recurrent tumor, vigorous attempts to achieve locoregional control, and the addition of systemic chemotherapy are all important in achieving better results. We routinely perform conventional cervical and abdominal ultrasonography and computed tomography every 6 months until 6 years after surgery is performed.

<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.